Csl Behring AG
CSL Behring AG, a global leader in biotherapeutics, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 1904, the company has established itself in the biotechnology industry, specialising in the development and manufacture of innovative therapies for rare and serious diseases. CSL Behring is renowned for its high-quality plasma-derived products, including immunoglobulins, clotting factors, and albumin, which are essential for treating conditions such as haemophilia and immune deficiencies. The company’s commitment to research and development has led to significant advancements in patient care, positioning it as a trusted name in the healthcare sector. With a strong market presence and a dedication to improving patient outcomes, CSL Behring AG continues to achieve notable milestones, reinforcing its reputation as a pioneer in the biopharmaceutical landscape.
DitchCarbon Score
How does Csl Behring AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Csl Behring AG's score of 30 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Csl Behring AG's reported carbon emissions
Csl Behring AG, headquartered in Switzerland (CH), currently does not provide specific carbon emissions data or reduction targets. Without available figures, it is unclear what their current emissions levels are or the scope of their emissions (Scope 1, 2, or 3). However, the company is likely engaged in various climate commitments typical of the biopharmaceutical industry, focusing on sustainability and reducing environmental impact. As the industry increasingly prioritises carbon neutrality and climate resilience, Csl Behring AG may be exploring initiatives to align with these trends. For a comprehensive understanding of their climate strategy, further information would be necessary regarding any specific commitments or initiatives they may have undertaken.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Csl Behring AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
